Form 8-K - Current report:
SEC Accession No. 0001193125-14-446929
Filing Date
2014-12-18
Accepted
2014-12-18 16:17:33
Documents
1
Period of Report
2014-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d838780d8k.htm 8-K 10760
  Complete submission text file 0001193125-14-446929.txt   11839
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 141295955
SIC: 2834 Pharmaceutical Preparations